Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally - Comment

被引：0
|
作者：
Okamura, Kikuo [1 ]
机构：
[1] Natl Ctr Geriatr & Gerontol, Dept Surg & Intens Care, Div Urol, Aichi, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2007年 / 14卷 / 04期
关键词：
D O I：
10.1111/j.1442-2042.2007.01762.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [31] Usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia in view of global polyuria
    Yoo, Sangjun
    Park, Juhyun
    Cho, Sung Yong
    Cho, Min Chul
    Jeong, Hyeon
    Son, Hwancheol
    PLOS ONE, 2018, 13 (07):
  • [32] Reliability of the international prostate symptom score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia
    elDin, KE
    Koch, WFRM
    deWildt, MJAM
    Kiemeney, LALM
    Debruyne, FMJ
    delaRosette, JJMCH
    JOURNAL OF UROLOGY, 1996, 155 (06): : 1959 - 1964
  • [33] Re: Should Modest Elevations in Prostate-Specific Antigen, International Prostate Symptom Score, or their Rates of Increase over Time be Used as Surrogate Measures of Incident Benign Prostatic Hyperplasia? Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2014, 192 (01): : 162 - 163
  • [34] Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population
    Taneja, Yogesh
    Ram, Priyatama
    Kumar, Satish
    Raj, Kishan
    Singh, Charan K.
    Dhaked, Santosh K.
    Jaipuria, Jiten
    PROSTATE INTERNATIONAL, 2017, 5 (04) : 158 - 161
  • [35] Should Modest Elevations in Prostate-Specific Antigen, International Prostate Symptom Score, or Their Rates of Increase Over Time be Used as Surrogate Measures of Incident Benign Prostatic Hyperplasia?
    Schenk, Jeannette M.
    Hunter-Merrill, Rachel
    Zheng, Yingye
    Etzioni, Ruth
    Gulati, Roman
    Tangen, Catherine
    Thompson, Ian M.
    Kristal, Alan R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (05) : 741 - 751
  • [36] EFFICACY OF DUTASTERIDE ON BENIGN PROSTATIC HYPERPLASIA ENDPOINTS IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY ACCORDING TO BASELINE INTERNATIONAL PROSTATE SYMPTOM SCORE AND PROSTATE VOLUME
    Roehrborn, Claus G.
    Pettaway, Curtis A.
    Nickel, J. Curtis
    Tammela, Teuvo L. J.
    Teloken, Claudio
    Somerville, Matthew C.
    Wilson, Timothy H.
    Rittmaster, Roger S.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E691 - E691
  • [37] The effect of finasteride on prostate volume, urinary flow rate and symptom score in men with benign prostatic hyperplasia
    Nacey, JN
    Meffan, PJ
    Delahunt, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1995, 65 (01): : 35 - 39
  • [38] Changes in serum prostate specific antigen after transurethral resection of prostate in patients with benign prostatic hyperplasia
    Hari, K. C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 118 - 118
  • [39] Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia
    Sciarra, A
    D'Eramo, G
    Casale, P
    Loreto, A
    Buscarini, M
    Di Nicola, S
    Seccareccia, F
    Di Silverio, F
    PROSTATE, 1998, 34 (02): : 121 - 128
  • [40] Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression
    Levitt J.M.
    Slawin K.M.
    Current Urology Reports, 2007, 8 (4) : 269 - 274
12345